309 related articles for article (PubMed ID: 35757923)
1. Natural and genetically-modified animal models to investigate pulmonary and extrapulmonary manifestations of COVID-19.
Tiwari S; Goel G; Kumar A
Int Rev Immunol; 2024; 43(1):13-32. PubMed ID: 35757923
[TBL] [Abstract][Full Text] [Related]
2. Animal Models of COVID-19. I. Comparative Virology and Disease Pathogenesis.
Zeiss CJ; Compton S; Veenhuis RT
ILAR J; 2021 Dec; 62(1-2):35-47. PubMed ID: 33836527
[TBL] [Abstract][Full Text] [Related]
3. Ferrets: A powerful model of SARS-CoV-2.
Zhao Y; Wang CL; Gao ZY; Qiao HX; Wang WJ; Liu XY; Chuai X
Zool Res; 2023 Mar; 44(2):323-330. PubMed ID: 36799224
[TBL] [Abstract][Full Text] [Related]
4. Animal Models of COVID-19 II. Comparative Immunology.
Veenhuis RT; Zeiss CJ
ILAR J; 2021 Dec; 62(1-2):17-34. PubMed ID: 33914873
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 immunity in animal models.
Chen Z; Yuan Y; Hu Q; Zhu A; Chen F; Li S; Guan X; Lv C; Tang T; He Y; Cheng J; Zheng J; Hu X; Zhao J; Zhao J; Sun J
Cell Mol Immunol; 2024 Feb; 21(2):119-133. PubMed ID: 38238440
[TBL] [Abstract][Full Text] [Related]
6. Review of selected animal models for respiratory coronavirus infection and its application in drug research.
Qin S; Li R; Zheng Z; Zeng X; Wang Y; Wang X
J Med Virol; 2022 Jul; 94(7):3032-3042. PubMed ID: 35285034
[TBL] [Abstract][Full Text] [Related]
7. Alternatives to animal models and their application in the discovery of species susceptibility to SARS-CoV-2 and other respiratory infectious pathogens: A review.
Runft S; Färber I; Krüger J; Krüger N; Armando F; Rocha C; Pöhlmann S; Burigk L; Leitzen E; Ciurkiewicz M; Braun A; Schneider D; Baumgärtner L; Freisleben B; Baumgärtner W
Vet Pathol; 2022 Jul; 59(4):565-577. PubMed ID: 35130766
[TBL] [Abstract][Full Text] [Related]
8. Animal models and SARS-CoV-2-induced pulmonary and neurological injuries.
Pinto MA; da Silva ADS; Rodrigues DDRF; Müller R; de Vasconcelos GALBM; Neves PCDC; de Oliveira JM; Marchevsky RS
Mem Inst Oswaldo Cruz; 2023; 117():e220239. PubMed ID: 36700583
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice.
Winkler ES; Chen RE; Alam F; Yildiz S; Case JB; Uccellini MB; Holtzman MJ; Garcia-Sastre A; Schotsaert M; Diamond MS
J Virol; 2022 Jan; 96(1):e0151121. PubMed ID: 34668780
[TBL] [Abstract][Full Text] [Related]
10. Experimental Models of COVID-19.
Caldera-Crespo LA; Paidas MJ; Roy S; Schulman CI; Kenyon NS; Daunert S; Jayakumar AR
Front Cell Infect Microbiol; 2021; 11():792584. PubMed ID: 35096645
[TBL] [Abstract][Full Text] [Related]
11. Severe acute respiratory syndrome coronavirus-2 natural animal reservoirs and experimental models: systematic review.
Younes S; Younes N; Shurrab F; Nasrallah GK
Rev Med Virol; 2021 Jul; 31(4):e2196. PubMed ID: 33206434
[TBL] [Abstract][Full Text] [Related]
12. Transmission and Protection against Reinfection in the Ferret Model with the SARS-CoV-2 USA-WA1/2020 Reference Isolate.
Patel DR; Field CJ; Septer KM; Sim DG; Jones MJ; Heinly TA; Vanderford TH; McGraw EA; Sutton TC
J Virol; 2021 Jun; 95(13):e0223220. PubMed ID: 33827954
[TBL] [Abstract][Full Text] [Related]
13. Ferrets are valuable models for SARS-CoV-2 research.
Ciurkiewicz M; Armando F; Schreiner T; de Buhr N; Pilchová V; Krupp-Buzimikic V; Gabriel G; von Köckritz-Blickwede M; Baumgärtner W; Schulz C; Gerhauser I
Vet Pathol; 2022 Jul; 59(4):661-672. PubMed ID: 35001763
[TBL] [Abstract][Full Text] [Related]
14. Animal models for COVID-19: advances, gaps and perspectives.
Fan C; Wu Y; Rui X; Yang Y; Ling C; Liu S; Liu S; Wang Y
Signal Transduct Target Ther; 2022 Jul; 7(1):220. PubMed ID: 35798699
[TBL] [Abstract][Full Text] [Related]
15. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.
Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A
mBio; 2021 Apr; 12(2):. PubMed ID: 33879586
[TBL] [Abstract][Full Text] [Related]
16. Animals and SARS-CoV-2: Species susceptibility and viral transmission in experimental and natural conditions, and the potential implications for community transmission.
Hobbs EC; Reid TJ
Transbound Emerg Dis; 2021 Jul; 68(4):1850-1867. PubMed ID: 33091230
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 Aerosol and Intranasal Exposure Models in Ferrets.
Zumbrun EE; Zak SE; Lee ED; Bowling PA; Ruiz SI; Zeng X; Koehler JW; Delp KL; Bakken RR; Hentschel SS; Bloomfield HA; Ricks KM; Clements TL; Babka AM; Dye JM; Herbert AS
Viruses; 2023 Nov; 15(12):. PubMed ID: 38140582
[TBL] [Abstract][Full Text] [Related]
18. Age-Related Susceptibility of Ferrets to SARS-CoV-2 Infection.
Martins M; Fernandes MHV; Joshi LR; Diel DG
J Virol; 2022 Feb; 96(3):e0145521. PubMed ID: 34817200
[TBL] [Abstract][Full Text] [Related]
19. Animal models for studying COVID-19, prevention, and therapy: Pathology and disease phenotypes.
Choudhary S; Kanevsky I; Tomlinson L
Vet Pathol; 2022 Jul; 59(4):516-527. PubMed ID: 35451341
[TBL] [Abstract][Full Text] [Related]
20. Characterization of young and aged ferrets as animal models for SARS-CoV-2 infection with focus on neutrophil extracellular traps.
Pilchová V; Gerhauser I; Armando F; Wirz K; Schreiner T; de Buhr N; Gabriel G; Wernike K; Hoffmann D; Beer M; Baumgärtner W; von Köckritz-Blickwede M; Schulz C
Front Immunol; 2023; 14():1283595. PubMed ID: 38169647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
